• image.alt
  • With Mayo Clinic rheumatologist

    April Chang-Miller, M.D.

    read biography
The Mayo Clinic Diet Book, learn more

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Question

Osteoporosis and long-term prednisone: What is the risk?

I've been taking prednisone for my rheumatoid arthritis, but I've heard that it can increase my chances of developing osteoporosis. How big is the risk?

Answer

Controlling Your Arthritis

Subscribe to our Controlling Your Arthritis e-newsletter
for tips to manage arthritis.

Sign up now
from April Chang-Miller, M.D.

Prednisone and similar drugs all cause bone loss. It's difficult, however, to separate prednisone use from the other things that might increase your risk of osteoporosis — your age, your sex and some aspects of your lifestyle, for example. Rheumatoid arthritis itself can lead to bone loss.

Prednisone is a corticosteroid (kor-tih-ko-STARE-oid) medication, highly effective for treating inflammation in rheumatoid arthritis and many other conditions. Unfortunately, corticosteroids also interfere with bone maintenance and limit the amount of calcium absorbed by your intestines. This can dramatically weaken bones and lead to osteoporosis.

In general, the higher the dose of prednisone you take and the longer you take it, the greater the risk. To counter the risk, do weightbearing exercise, avoid alcohol and do not smoke. Taking calcium and vitamin D supplements also can help reduce the amount of bone loss caused by steroids such as prednisone.

If you'll be taking prednisone for more than a few months and you have other risk factors for bone loss, your doctor may prescribe medications specifically designed to treat osteoporosis.

Next question
Rheumatoid arthritis diet: Do certain foods reduce symptoms?
References
  1. Grossman JM, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care & Research. 2010;62:1515. http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2151-4658. Accessed March 21, 2011.
  2. Rosen HN. Pathogenesis and clinical features of glucocorticoid-induced osteoporosis. http://uptodate.com/home/index.html. Accessed March 22, 2011.
  3. den Uyl D, et al. Advances in glucocorticoid-induced osteoporosis. Current Rheumatology Reports. In press. http://www.springerlink.com/content/h7526480765p4648. Accessed March 22, 2011.
AN01972 March 31, 2011

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger